Shelemba Evgeniya, Olshanska Olha, Benoit Anne Gaelle, Rumyantseva Elena
P.L. Shypuk National Medical Academy of Post-Graduate Education, Kyiv, Ukraine.
Innovaesthetic, Kyiv, Ukraine.
J Cosmet Dermatol. 2025 Jan;24(1):e16586. doi: 10.1111/jocd.16586. Epub 2024 Sep 15.
Skin aging research often focuses on the dermis, overlooking the significance of the retinacular cutis (RC) in aging. This study aimed to investigate the efficacy, safety, and effect of an injectable solution containing hyaluronic acid, amino acids, and peptides, on facial sagging and laxity by targeting the RC.
This single-center observational study recruited 28 female volunteers aged 25-65 years. The participants received four monthly injections of the studied solution. Objective measures included skin hydration, elasticity, color, thickness, collagen density evaluated via DermaLab Combo and high-resolution ultrasound imaging. Subjective measures included participant satisfaction evaluated using the Global Aesthetic Improvement Scale (GAIS). Adverse effects were monitored throughout the study period.
Significant improvements were observed in skin hydration, elasticity, and collagen density after treatment. Hydration increased by 25.9% at T1 (30 days after last session), sustaining a 15.9% increase at T2 (120 days after last session). Elasticity improved by 29.2% at T1 and 20.7% at T2. Collagen density increased by 20.27% at T1 and 16.71% at T2. Self-reported GAIS scores showed consistent increases. Adverse effects were minimal and included only transient ecchymosis and mild pain.
Injections of the solution had a substantial hydrating effect, enhanced elasticity, and increased collagen density in the RC and dermis. Results persisted at the 120-day follow-up, indicating sustained benefits. Hence, this injectable solution may offer a safe and effective non-invasive treatment option for improving skin laxity and sagging, targeting the RC and other deep connective tissue such as retaining ligaments.
皮肤衰老研究通常聚焦于真皮层,而忽视了网状皮肤(RC)在衰老过程中的重要性。本研究旨在探讨一种含有透明质酸、氨基酸和肽的注射溶液,通过针对RC来改善面部松弛和下垂的疗效、安全性及效果。
这项单中心观察性研究招募了28名年龄在25 - 65岁之间的女性志愿者。参与者每月接受4次研究溶液注射。客观测量指标包括通过DermaLab Combo和高分辨率超声成像评估的皮肤水分含量、弹性、颜色、厚度、胶原蛋白密度。主观测量指标包括使用全球美学改善量表(GAIS)评估参与者的满意度。在整个研究期间监测不良反应。
治疗后皮肤水分含量、弹性和胶原蛋白密度有显著改善。在T1(最后一次注射后30天)时水分含量增加了25.9%,在T2(最后一次注射后120天)时持续增加了15.9%。弹性在T1时提高了29.2%,在T2时提高了20.7%。胶原蛋白密度在T1时增加了20.27%,在T2时增加了16.71%。自我报告的GAIS评分显示持续上升。不良反应轻微,仅包括短暂的瘀斑和轻度疼痛。
注射该溶液对RC和真皮层有显著的保湿作用,增强了弹性,并增加了胶原蛋白密度。在120天的随访中结果持续存在,表明有持续的益处。因此,这种注射溶液可能为改善皮肤松弛和下垂提供一种安全有效的非侵入性治疗选择,针对RC和其他深部结缔组织如固定韧带。